WSB2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.873800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.999000E-01
Normal-vs-Stage2
5.024600E-01
Normal-vs-Stage3
8.653600E-01
Normal-vs-Stage4
3.732000E-01
Stage1-vs-Stage2
8.448000E-01
Stage1-vs-Stage3
7.514400E-01
Stage1-vs-Stage4
1.444850E-01
Stage2-vs-Stage3
6.766800E-01
Stage2-vs-Stage4
4.363000E-01
Stage3-vs-Stage4
4.586600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.662200E-01
Normal-vs-AfricanAmerican
8.058200E-01
Normal-vs-Asian
9.890400E-01
Caucasian-vs-AfricanAmerican
5.479200E-01
Caucasian-vs-Asian
1.621010E-01
AfricanAmerican-vs-Asian
6.781600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.488400E-01
Normal-vs-Female
5.218800E-01
Male-vs-Female
8.260200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.718200E-01
Normal-vs-Age(41-60Yrs)
2.727000E-01
Normal-vs-Age(61-80Yrs)
6.062600E-01
Normal-vs-Age(81-100Yrs)
8.470800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.861000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.404000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.744800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.697900E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.169700E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.588800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.696000E-01
Normal-vs-Daily Drinker
6.946800E-01
Normal-vs-Weekly Drinker
5.648800E-01
Normal-vs-Occasional Drinker
2.685000E-01
Normal-vs-Social Drinker
4.582600E-01
Non Drinker-vs-Daily Drinker
3.713200E-01
Non Drinker-vs-Weekly Drinker
2.327000E-01
Non Drinker-vs-Occasional Drinker
1.599930E-02
Non Drinker-vs-Social Drinker
1.166240E-01
Daily Drinker-vs-Weekly Drinker
7.620000E-01
Daily Drinker-vs-Occasional Drinker
8.990300E-02
Daily Drinker-vs-Social Drinker
2.674200E-01
Weekly Drinker-vs-Occasional Drinker
2.026400E-01
Weekly Drinker-vs-Social Drinker
3.675200E-01
Occasional Drinker-vs-Social Drinker
9.614000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.499600E-01
Normal-vs-Grade 2
6.796600E-01
Normal-vs-Grade 3
6.527400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.651250E-01
Grade 1-vs-Grade 3
2.644600E-01
Grade 1-vs-Grade 4
3.499600E-01
Grade 2-vs-Grade 3
5.600000E-01
Grade 2-vs-Grade 4
6.796600E-01
Grade 3-vs-Grade 4
6.527400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.662600E-01
Normal-vs-NonDiabetic
5.034000E-01
Diabetic-vs-NonDiabetic
9.715600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.734600E-01
Normal-vs-NoPancreatitis
5.484200E-01
Pancreatitis-vs-NoPancreatitis
3.611000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.935000E-01
Normal-vs-N1
4.832600E-01
N0-vs-N1
3.098800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.894400E-01
Normal-vs-TP53-NonMutant
4.628400E-01
TP53-Mutant-vs-TP53-NonMutant
5.055800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
